Craft

Bausch + Lomb

Stock Price

$20.8

2024-10-29

Market Capitalization

$7.3 B

2024-10-29

Revenue

$4.8 B

FY, 2024

Bausch + Lomb Summary

Company Summary

Overview
Bausch + Lomb is a company that develops, manufactures, and markets eye health products. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment offers contact lenses and consumer eye care solutions. The Pharmaceuticals segment provides products for a post-operative period and treatments for glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment specializes in IOLs and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery.
Type
Public
Status
Active
Founded
1853
HQ
Vaughan, CA | view all locations
Website
https://www.bausch.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Brent Saunders

    Brent Saunders, Chief Executive Officer and Chairman of the Board

  • Sam Eldessouky

    Sam Eldessouky, Executive Vice President and Chief Financial Officer

  • Bob Bailey

    Bob Bailey, Executive Vice President and Chief Legal Officer

  • Yehia Hashad

    Yehia Hashad, Executive Vice President of Research & Development and Chief Medical Officer

Operating MetricsView all

Countries (Customers)

100

FY, 2022

Facility Space Owned, sq. ft.

3.4M
7.8%

FY, 2022

Facility Space Leased, sq. ft.

808K

FY, 2022

LocationsView all

45 locations detected

  • Vaughan, ON HQ

    Canada

    520 Applewood Crescent

  • Ballwin, MO

    United States

    499 Sovereign Ct

  • Clearwater, FL

    United States

    21 N Park Pl Blvd

  • Greenville, SC

    United States

    8507 Pelham Rd

  • Irvine, CA

    United States

    15272 Alton Pkwy #200

  • Lynchburg, VA

    United States

    1501 Graves Mill Rd

and 39 others

Bausch + Lomb Financials

Summary Financials

Revenue (FY, 2024)
$4.8B
Gross profit (FY, 2024)
$2.9B
Net income (FY, 2024)
($305.0M)
Cash (FY, 2024)
$305.0M
EBIT (FY, 2024)
$162.0M
Enterprise value
$11.8B

Footer menu